{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:15:59Z","timestamp":1791170159677,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.cpet.2010.12.003","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T15:41:13Z","timestamp":1300290073000},"page":"71-77","source":"Crossref","is-referenced-by-count":2,"title":["Preclinical Studies with Small Animal PET"],"prefix":"10.1016","volume":"6","author":[{"given":"Cristina","family":"Nanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpet.2010.12.003_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics, 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cpet.2010.12.003_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(05)70937-5","article-title":"Cutaneous melanoma","volume":"365","author":"Thompson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cpet.2010.12.003_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3322\/canjclin.54.3.131","article-title":"An evidence-based staging system for cutaneous melanoma","volume":"54","author":"Balch","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cpet.2010.12.003_bib4","first-page":"957","article-title":"Role of nuclear medicine in the management of cutaneous malignant melanoma","volume":"27","author":"Belhocine","year":"2006","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2010.12.003_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1148\/radiol.2312021185","article-title":"Clinical applications of PET in oncology","volume":"231","author":"Rohren","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.cpet.2010.12.003_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.rcl.2008.10.005","article-title":"Positron emission tomography\/computed tomography: the current technology and applications","volume":"47","author":"Mittra","year":"2009","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.cpet.2010.12.003_bib7","first-page":"3","article-title":"Clinical applications of 18F-FDG in oncology","volume":"30","author":"Nabi","year":"2002","journal-title":"J\u00a0Nucl Med Technol"},{"key":"10.1016\/j.cpet.2010.12.003_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00702-004-0272-2","article-title":"Micropet imaging: in vivo biochemistry in small animals","volume":"112","author":"Sossi","year":"2005","journal-title":"J\u00a0Neural Transm"},{"issue":"11","key":"10.1016\/j.cpet.2010.12.003_bib9","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00259-004-1683-x","article-title":"Small animal PET: aspects of performance assessment","volume":"31","author":"Weber","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2010.12.003_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/path.1697","article-title":"Advances in imaging mouse tumour models in vivo","volume":"205","author":"Lyons","year":"2005","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.cpet.2010.12.003_bib11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0924-977X(02)00103-7","article-title":"Small animal PET","volume":"12","author":"Myers","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.cpet.2010.12.003_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11307-006-0052-5","article-title":"Longitudinally quantitative 2-deoxy-2-[18F]fluoro-D-glucose micro positron emission tomography imaging for efficacy of new anticancer drugs: a case study with bortezomib in prostate cancer murine model","volume":"8","author":"Zhang","year":"2006","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.cpet.2010.12.003_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0952-7915(03)00066-9","article-title":"Micro-PET imaging and small animal models of disease","volume":"15","author":"Herschman","year":"2003","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1016\/j.cpet.2010.12.003_bib14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00259-006-0288-y","article-title":"FDG small animal PET permits early detection of malignant cells in a xenograft murine model","volume":"34","author":"Nanni","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2010.12.003_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00008390-200209000-00001","article-title":"Skin colour and skin cancer: MC1R, the genetic link","volume":"12","author":"Sturm","year":"2002","journal-title":"Melanoma Res"},{"key":"10.1016\/j.cpet.2010.12.003_bib16","first-page":"6352","article-title":"Characterization of receptors for alphamelanocyte-stimulating hormone on human melanoma cells","volume":"49","author":"Siegrist","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.cpet.2010.12.003_bib17","first-page":"2604","article-title":"Homologous and heterologous regulation of alpha-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines","volume":"54","author":"Siegrist","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.cpet.2010.12.003_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0969-8051(96)00211-9","article-title":"Fluorine-18-labeled [Nle4, D-Phe7]-alpha-MSH, an alpha-melanocyte stimulating hormone analogue","volume":"24","author":"Vaidyanathan","year":"1997","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.cpet.2010.12.003_bib19","first-page":"5649","article-title":"Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues","volume":"60","author":"Chen","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cpet.2010.12.003_bib20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0969-8051(99)00032-3","article-title":"In vivo evaluation of 99mTc\/188Re-labeled linear alpha-melanocyte stimulating hormone analogs for specific melanoma targeting","volume":"26","author":"Chen","year":"1999","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.cpet.2010.12.003_bib21","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1021\/jm010408m","article-title":"Modification of the structure of a metallopeptide: synthesis and biological evaluation of 111In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues","volume":"45","author":"Cheng","year":"2002","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.cpet.2010.12.003_bib22","first-page":"1847","article-title":"Evaluation of an 111In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor targeting properties","volume":"42","author":"Chen","year":"2001","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2010.12.003_bib23","first-page":"1699","article-title":"A\u00a0novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis","volume":"43","author":"Froidevaux","year":"2002","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2010.12.003_bib24","first-page":"887","article-title":"Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake","volume":"46","author":"Froidevaux","year":"2005","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2010.12.003_bib25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ijc.2910580521","article-title":"[111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo","volume":"58","author":"Bagutti","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cpet.2010.12.003_bib26","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00006231-199510000-00010","article-title":"An improved imaging agent for malignant melanoma, based on [Nle4, D-Phe7]alpha-melanocyte stimulating hormone","volume":"16","author":"Bard","year":"1995","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.cpet.2010.12.003_bib27","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1158\/0008-5472.CAN-03-0193","article-title":"Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma","volume":"64","author":"Cheng","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cpet.2010.12.003_bib28","first-page":"116","article-title":"A\u00a0gallium-labeled DOTA-alpha-melanocyte-stimulating hormone analog for PET imaging of melanoma metastases","volume":"45","author":"Froidevaux","year":"2004","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2010.12.003_bib29","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1021\/jm0490282","article-title":"Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH","volume":"48","author":"McQuade","year":"2005","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.cpet.2010.12.003_bib30","first-page":"126","article-title":"MicroPET imaging of melanoma using Cu-64 labeled alpha-melanocyte stimulating hormone peptide analogue","volume":"7","author":"Cheng","year":"2005","journal-title":"Mol Imaging Biol"},{"issue":"3","key":"10.1016\/j.cpet.2010.12.003_bib31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/bc060306g","article-title":"64Cu labeled alphamelanocyte stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression","volume":"18","author":"Cheng","year":"2007","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.cpet.2010.12.003_bib32","first-page":"121","article-title":"Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models","volume":"46","author":"Miao","year":"2005","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2010.12.003_bib33","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1158\/1078-0432.CCR-05-0619","article-title":"Melanoma therapy via peptide-targeted a-radiation","volume":"11","author":"Miao","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.cpet.2010.12.003_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.nucmedbio.2009.01.007","article-title":"Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A\u2032-Re(Arg11)CCMSH","volume":"36","author":"Wei","year":"2009","journal-title":"Nucl Med Biol"},{"issue":"8","key":"10.1016\/j.cpet.2010.12.003_bib35","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.nucmedbio.2007.07.003","article-title":"Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma","volume":"34","author":"Wei","year":"2007","journal-title":"Nucl Med Biol"},{"issue":"6","key":"10.1016\/j.cpet.2010.12.003_bib36","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2967\/jnumed.107.039602","article-title":"Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog","volume":"48","author":"Cheng","year":"2007","journal-title":"J\u00a0Nucl Med"},{"issue":"11","key":"10.1016\/j.cpet.2010.12.003_bib37","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2967\/jnumed.109.062877","article-title":"PET of malignant melanoma using 18F-labeled metallopeptides","volume":"50","author":"Ren","year":"2009","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2010.12.003_bib38","first-page":"3691","article-title":"Radioiodinated methylene blue: a promising agent for melanoma scintigraphy\u2013labelling, stability and in vitro uptake by melanoma cells","volume":"28","author":"Sobal","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cpet.2010.12.003_bib39","first-page":"299","article-title":"Diagnosis and follow up of primary ocular melanoma by radioimmunoscintigraphy","volume":"9","author":"Beatovic","year":"2004","journal-title":"J\u00a0BUON"},{"key":"10.1016\/j.cpet.2010.12.003_bib40","doi-asserted-by":"crossref","first-page":"17489","DOI":"10.1073\/pnas.0708436104","article-title":"Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates","volume":"104","author":"Voss","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cpet.2010.12.003_bib41","first-page":"404","article-title":"Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT","volume":"47","author":"Kato","year":"2006","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2010.12.003_bib42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.nucmedbio.2009.01.003","article-title":"Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide","volume":"36","author":"Guo","year":"2009","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.cpet.2010.12.003_bib43","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2967\/jnumed.107.048553","article-title":"203Pb-labeled a-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection","volume":"49","author":"Miao","year":"2008","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2010.12.003_bib44","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1021\/jm701424g","article-title":"Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma","volume":"51","author":"Chezal","year":"2008","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.cpet.2010.12.003_bib45","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1021\/jm0701627","article-title":"Synthesis and evaluation of novel radioiodinated benzamides for malignant melanoma","volume":"50","author":"Pham","year":"2007","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.cpet.2010.12.003_bib46","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s00259-002-0971-6","article-title":"123I-N-(2-diethylaminoethyl)-2- iodobenzamide: a potential imaging agent for cutaneous melanoma staging","volume":"29","author":"Moins","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2010.12.003_bib47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0181-5512(04)96089-5","article-title":"Phase 2 clinical study of 123IN-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma","volume":"27","author":"Sillaire-Houtmann","year":"2004","journal-title":"J\u00a0Fr Ophtalmol"},{"key":"10.1016\/j.cpet.2010.12.003_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1034\/j.1600-0420.1998.760110.x","article-title":"Clinical study of [123I] N-(2-diethylaminoethyl)-4-iodobenzamide in the diagnosis of primary and metastatic ocular melanoma","volume":"76","author":"Bacin","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.cpet.2010.12.003_bib49","first-page":"996","article-title":"Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo","volume":"39","author":"Larisch","year":"1998","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2010.12.003_bib50","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1021\/jm9008423","article-title":"Discovery of [18F]N-(2-(diethylamino) ethyl)-6-fluoronicotinamide: a melanoma positron emission tomography imaging radiotracer with high tumor to body contrast ratio and\u00a0rapid renal clearance","volume":"52","author":"Greguric","year":"2009","journal-title":"J\u00a0Med Chem"},{"issue":"3","key":"10.1016\/j.cpet.2010.12.003_bib51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2967\/jnumed.109.070060","article-title":"High-contrast PET of melanoma using (18)F-MEL050, a selective probe for melanin with predominantly renal clearance","volume":"51","author":"Denoyer","year":"2010","journal-title":"J\u00a0Nucl Med"},{"issue":"10","key":"10.1016\/j.cpet.2010.12.003_bib52","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.2967\/jnumed.109.066175","article-title":"Melanin-targeted preclinical PET imaging of melanoma metastasis","volume":"50","author":"Ren","year":"2009","journal-title":"J\u00a0Nucl Med"},{"issue":"6","key":"10.1016\/j.cpet.2010.12.003_bib53","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00259-003-1152-y","article-title":"A\u00a0new animal model for the imaging of melanoma: correlation of FDG PET with clinical outcome, macroscopic aspect and histological classification in Melanoblastoma-bearing Libechov Minipigs","volume":"30","author":"Boisgard","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859810001264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859810001264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T19:23:53Z","timestamp":1543865033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859810001264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1556859810001264"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2010.12.003","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}